Please check your internet connection and try again.
# Urimax (Tamsulosin)
## Overview
Tamsulosin is a selective α1-adrenoceptor antagonist that preferentially blocks α1A receptors in the prostate and bladder neck, causing smooth muscle relaxation and improving urinary flow.
## Primary Indications
* Treatment of signs and symptoms of benign prostatic hyperplasia (BPH).
* Off-label: Medical expulsive therapy for ureteral calculi.
## Adult Dosing
* **BPH:** 0.4 mg orally once daily, taken 30 minutes after the same meal each day.
* If no response after 2–4 weeks, the dose may be increased to 0.8 mg once daily.
* **Maximum Dose:** 0.8 mg daily.
## Pediatric Dosing
* **Safety and efficacy not established.** Use is generally off-label and requires specialist guidance (e.g., for neurogenic bladder). Dose varies by institutional protocol; clinical studies in children are limited.
## Dose Adjustments
* **Renal Impairment:** No dosage adjustment necessary for mild to moderate impairment. Use caution in patients with severe impairment (CrCl <10 mL/min); data is limited.
* **Hepatic Impairment:** No dosage adjustment for mild to moderate impairment. Avoid in severe hepatic impairment.
## Contraindications
* Hypersensitivity to tamsulosin or any component of the formulation.
* Severe hepatic impairment.
* Concurrent use with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin).
## Adverse Effects
* **Common:** Dizziness, headache, abnormal ejaculation (retrograde or decreased volume), rhinitis, orthostatic hypotension.
* **Serious:** Syncope (especially with the first dose or after a dose increase), priapism, Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery.
## Key Drug Interactions
* **CYP3A4 Inhibitors:** May significantly increase tamsulosin serum levels; monitor for hypotension.
* **PDE5 Inhibitors:** Concomitant use (e.g., sildenafil, tadalafil) may result in additive hypotensive effects; initiate PDE5 inhibitor at the lowest possible dose.
* **Antihypertensives:** Potential for additive blood pressure lowering effects.
## Monitoring
* Monitor blood pressure periodically, particularly in the elderly or those on concurrent antihypertensives.
* Assess symptom improvement (e.g., I-PSS score) after 2–4 weeks.
* Rule out prostate carcinoma prior to treatment initiation.
## Clinical Pearls
* **Administration:** Must be taken 30 minutes after the same meal every day to ensure consistent bioavailability. Swallow capsules whole; avoid crushing or chewing.
* **Cataract Surgery:** Patients should inform their ophthalmologist of tamsulosin use, as it significantly increases the risk of IFIS during phacoemulsification.
* **Syncope:** Advise patients to avoid rising rapidly from a sitting or lying position to minimize orthostatic hypotension risk.
***
**Educational Disclaimer:** This information is for educational purposes only. Tamsulosin dosing and clinical guidelines may vary based on local institutional protocols and individual patient-specific factors. Always verify current prescribing information, contraindications, and drug interactions with official manufacturer labeling or a primary clinical pharmacy resource before prescribing or administering medication.
